Skip to main content

Table 3 Mean (SD) bone mineral density ratio (the BMD changes from baseline) for each group by gruen zone at different time points

From: Bone turnover and periprosthetic bone loss after cementless total hip arthroplasty can be restored by zoledronic acid: a prospective, randomized, open-label, controlled trial

Gruen zones

1

2

3

4

5

6

7

12 weeks

 ZA group

1.20(0.74)

1.18(0.28)a

1.13(0.62)

1.07(0.23)a

1.13(0.41)

1.13(0.13)a

1.15(0.21)a

 Control

0.93(0.14)

1.04(0.12)

0.98(0.08)

0.97(0.04)

1.00(0.07)

1.00(0.15)

0.93(0.22)

6 months

 ZA group

1.05(0.19)a

1.13(0.12)

1.05(0.21)

1.04(0.07)

1.04(0.18)

1.14(0.12)a

1.09(0.20)a

 Control

0.92(0.18)

1.07(0.19)

0.99(0.08)

0.97(0.06)

1.01(0.07)

1.02(0.18)

0.88(0.29)

1 year

 ZA group

1.05(0.19)a

1.10(0.10)a

1.00(0.09)

1.03(0.08)a

1.07(0.12)a

1.13(0.13)a

1.07(0.22)a

 Control

0.86(0.24)

0.98(0.25)

0.95(0.22)

0.93(0.20)

0.95(0.24)

0.97(0.28)

0.84(0.29)

2 years

 ZA group

1.08(0.21)a

1.12(0.11)

1.00(0.11)

1.04(0.09)a

1.08(0.15)

1.16(0.13)a

1.06(0.22)a

 Control

0.89(0.14)

1.10(0.46)

1.00(0.08)

0.96(0.07)

1.02(0.10)

1.00(0.19)

0.83(0.20)

  1. astatistically significant difference between the ZA and control groups (P < 0.05)
  2. BMD bone mineral density, SD standard deviation, ZA zoledronic acid